Compile Data Set for Download or QSAR
maximum 50k data
Found 764 with Last Name = 'shimizu' and Initial = 'k'
TargetThromboxane-A synthase(Homo sapiens (Human))
Nikken Chemicals

Curated by ChEMBL
LigandPNGBDBM50010960((E)-7-Phenyl-7-pyridin-3-yl-hept-6-enoic acid | 7-...)
Affinity DataIC50:  0.890nMAssay Description:In vitro inhibition of TXB2 production by incubating prostaglandin H2 with human platelet microsomes.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetThromboxane-A synthase(Homo sapiens (Human))
Nikken Chemicals

Curated by ChEMBL
LigandPNGBDBM50026486((Z)-7-Phenyl-7-pyridin-3-yl-hept-6-enoic acid | 7-...)
Affinity DataIC50:  0.900nMAssay Description:In vitro inhibition of thromboxane synthase (TXA2) in human platelet microsomes [reduced formation of TXB2 from prostaglandin H2(PGH2)]More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261482(US10011568, Ex. No. 5 | US9708266, 5)
Affinity DataIC50:  0.980nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261482(US10011568, Ex. No. 5 | US9708266, 5)
Affinity DataIC50:  0.980nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetThromboxane-A synthase(Homo sapiens (Human))
Nikken Chemicals

Curated by ChEMBL
LigandPNGBDBM50110458(5-(Phenyl-pyridin-3-yl-methyleneaminooxy)-pentanoi...)
Affinity DataIC50:  1nMAssay Description:In vitro inhibition of thromboxane synthase (TXA2) in human platelet microsomes [reduced formation of TXB2 from prostaglandin H2(PGH2)]More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261483(US10011568, Ex. No. 6 | US9708266, 6)
Affinity DataIC50:  1nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261483(US10011568, Ex. No. 6 | US9708266, 6)
Affinity DataIC50:  1nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetThromboxane-A synthase(Homo sapiens (Human))
Nikken Chemicals

Curated by ChEMBL
LigandPNGBDBM50109140(5-[1-Phenyl-1-pyridin-3-yl-meth-(Z)-ylideneaminoox...)
Affinity DataIC50:  1nMAssay Description:In vitro inhibition of TXB2 production by incubating prostaglandin H2 with human platelet microsomes.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetThromboxane-A synthase(Homo sapiens (Human))
Nikken Chemicals

Curated by ChEMBL
LigandPNGBDBM50109134(5-[1-Pyridin-3-yl-1-{3-[(3-pyridin-3-yl-1H-pyrrolo...)
Affinity DataIC50:  1.20nMAssay Description:In vitro inhibition of TXB2 production by incubating prostaglandin H2 with human platelet microsomes.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292016(US10100030, Example 11)
Affinity DataIC50:  1.32nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 uL/well. DMSO solutions of a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261478(US10011568, Ex. No. 1 | US9708266, 1)
Affinity DataIC50:  1.45nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261478(US10011568, Ex. No. 1 | US9708266, 1)
Affinity DataIC50:  1.45nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261490(US10011568, Ex. No. 13 | US9708266, 13)
Affinity DataIC50:  1.62nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261490(US10011568, Ex. No. 13 | US9708266, 13)
Affinity DataIC50:  1.62nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261484(US10011568, Ex. No. 7 | US9708266, 7)
Affinity DataIC50:  1.63nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261484(US10011568, Ex. No. 7 | US9708266, 7)
Affinity DataIC50:  1.63nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM158057(US9023882, 356)
Affinity DataIC50:  1.70nMT: 2°CAssay Description:Xanthine oxidase (from bovine milk, Sigma) was prepared with phosphate-buffered saline (PBS) at 0.02 units/mL, and then the solution was added to 96 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261479(US10011568, Ex. No. 2 | US9708266, 2)
Affinity DataIC50:  1.78nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261479(US10011568, Ex. No. 2 | US9708266, 2)
Affinity DataIC50:  1.78nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetThromboxane-A synthase(Homo sapiens (Human))
Nikken Chemicals

Curated by ChEMBL
LigandPNGBDBM50109124(5-[1-(3-{[4-(2-Methyl-imidazo[4,5-c]pyridin-1-ylme...)
Affinity DataIC50:  1.80nMAssay Description:In vitro inhibition of TXB2 production by incubating prostaglandin H2 with human platelet microsomes.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261480(US10011568, Ex. No. 3 | US9708266, 3)
Affinity DataIC50:  2.10nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM157874(US9023882, 147)
Affinity DataIC50:  2.10nMT: 2°CAssay Description:Xanthine oxidase (from bovine milk, Sigma) was prepared with phosphate-buffered saline (PBS) at 0.02 units/mL, and then the solution was added to 96 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261480(US10011568, Ex. No. 3 | US9708266, 3)
Affinity DataIC50:  2.10nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM157887(US9023882, 160)
Affinity DataIC50:  2.10nMT: 2°CAssay Description:Xanthine oxidase (from bovine milk, Sigma) was prepared with phosphate-buffered saline (PBS) at 0.02 units/mL, and then the solution was added to 96 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292006(US10100030, Example 1)
Affinity DataIC50:  2.11nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 uL/well. DMSO solutions of a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261491(US10011568, Ex. No. 14 | US9708266, 14)
Affinity DataIC50:  2.21nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261491(US10011568, Ex. No. 14 | US9708266, 14)
Affinity DataIC50:  2.21nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292013(US10100030, Example 8)
Affinity DataIC50:  2.25nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 uL/well. DMSO solutions of a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM157944(US9023882, 233)
Affinity DataIC50:  2.30nMT: 2°CAssay Description:Xanthine oxidase (from bovine milk, Sigma) was prepared with phosphate-buffered saline (PBS) at 0.02 units/mL, and then the solution was added to 96 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261486(US10011568, Ex. No. 9 | US9708266, 9)
Affinity DataIC50:  2.35nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261481(US10011568, Ex. No. 4 | US9708266, 4)
Affinity DataIC50:  2.35nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261486(US10011568, Ex. No. 9 | US9708266, 9)
Affinity DataIC50:  2.35nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261481(US10011568, Ex. No. 4 | US9708266, 4)
Affinity DataIC50:  2.35nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261497(US10011568, Ex. No. 21 | US9708266, 21)
Affinity DataIC50:  2.36nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261497(US10011568, Ex. No. 21 | US9708266, 21)
Affinity DataIC50:  2.36nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM157880(US9023882, 153)
Affinity DataIC50:  2.40nMT: 2°CAssay Description:Xanthine oxidase (from bovine milk, Sigma) was prepared with phosphate-buffered saline (PBS) at 0.02 units/mL, and then the solution was added to 96 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM158072(US9023882, 371)
Affinity DataIC50:  2.40nMT: 2°CAssay Description:Xanthine oxidase (from bovine milk, Sigma) was prepared with phosphate-buffered saline (PBS) at 0.02 units/mL, and then the solution was added to 96 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM157875(US9023882, 148)
Affinity DataIC50:  2.5nMT: 2°CAssay Description:Xanthine oxidase (from bovine milk, Sigma) was prepared with phosphate-buffered saline (PBS) at 0.02 units/mL, and then the solution was added to 96 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292007(US10100030, Example 2)
Affinity DataIC50:  2.53nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 uL/well. DMSO solutions of a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292011(US10100030, Example 6)
Affinity DataIC50:  2.60nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 uL/well. DMSO solutions of a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM157886(US9023882, 159)
Affinity DataIC50:  2.70nMT: 2°CAssay Description:Xanthine oxidase (from bovine milk, Sigma) was prepared with phosphate-buffered saline (PBS) at 0.02 units/mL, and then the solution was added to 96 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261492(US10011568, Ex. No. 16 | US9708266, 16)
Affinity DataIC50:  2.78nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261492(US10011568, Ex. No. 16 | US9708266, 16)
Affinity DataIC50:  2.78nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261487(US10011568, Ex. No. 10 | US9708266, 10)
Affinity DataIC50:  2.79nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261487(US10011568, Ex. No. 10 | US9708266, 10)
Affinity DataIC50:  2.79nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM157954(US9023882, 245)
Affinity DataIC50:  2.80nMT: 2°CAssay Description:Xanthine oxidase (from bovine milk, Sigma) was prepared with phosphate-buffered saline (PBS) at 0.02 units/mL, and then the solution was added to 96 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292014(US10100030, Example 9)
Affinity DataIC50:  2.83nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 uL/well. DMSO solutions of a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM157970(US9023882, 262)
Affinity DataIC50:  3.10nMT: 2°CAssay Description:Xanthine oxidase (from bovine milk, Sigma) was prepared with phosphate-buffered saline (PBS) at 0.02 units/mL, and then the solution was added to 96 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM158054(US9023882, 352)
Affinity DataIC50:  3.20nMT: 2°CAssay Description:Xanthine oxidase (from bovine milk, Sigma) was prepared with phosphate-buffered saline (PBS) at 0.02 units/mL, and then the solution was added to 96 ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261496(US10011568, Ex. No. 20 | US9708266, 20)
Affinity DataIC50:  3.27nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 764 total ) | Next | Last >>
Jump to: